SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Bolt, Beranek & Newman [BBN]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Manish Dharwadker who wrote ()6/6/1996 3:30:00 PM
From: John A. Young   of 307
 
Business Wire News and comment.

I've followed BBN for months. They have excellent partners (AT&T), strong sales demand, KEY backbone components, top tier technology, and a cool we site. Why are they trcaking lower???? I'm confused. Can anybody explain?

Ps. This just in from Business Wire. Good news?? Why are they down again?

--(BUSINESS WIRE)--

Who: BBN Domain

What: BBN Domain will preview and demonstrate Clintrial 4, its

innovative new client/server clinical research software

product suite for pharmaceutical, biotechnology and

medical device companies and contract research

organizations, at the Drug Information Association (DIA)

32nd Annual Meeting on June 9-13, San Diego. Clintrial

4 helps companies successfully respond to time-to-market

pressures and global business requirements by turning

clinical data into easily accessible information.

Clintrial 4 is scheduled for commercial availability in

August 1996.

Clintrial 4 is based on BBN Domain's Clintrial 3, the

industry standard for clinical data management software,

used by more than 100 of the leading health care

companies worldwide.

BBN Domain also will demonstrate its Clintrace and

Integrated Review products. Clintrace is a

comprehensive database software application for

reporting and tracking adverse events. Integrated

Review is a medical data review tool that makes it easy

to access, review, and graph and report clinical data

directly from both Clintrial and Clintrace.

When: June 9-13, 1996

Where: Drug Information Association 32nd Annual Meeting

San Diego Convention Center

Booths No.: 709, 711, 713 -0-

BBN Domain, a wholly owned subsidiary of BBN Corp. (NYSE:BBN), provides
software and services that help
companies optimize their processes so they can deliver high-quality products to market
faster. The company's
networked software embodies data management, data analysis and domain-specific
methodologies in a visually oriented,
client/server environment. The company's products include Clintrace and Clintrial for
the pharmaceutical industry, and
Cornerstone, BBN/Patterns, BBN/Probe and the RS/Series for manufacturers. BBN
Domain is headquartered in
Cambridge, Mass.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext